시장보고서
상품코드
2060288

인공심장 시장 분석 및 예측 : 유형, 제품 유형, 기술, 구성부품, 용도, 재료 유형, 디바이스, 최종 사용자, 기능, 솔루션(-2035년)

Artificial Heart Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Material Type, Device, End User, Functionality, Solutions

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 7,246,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,772,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 10,297,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 인공심장 시장은 2025년 35억 달러에서 2035년까지 69억 달러로 확대되어 CAGR은 6.7%를 나타낼 것으로 예측됩니다. 인공심장 시장은 전체 인공심장(TAH)과 심실 보조 장치(VAD)라는 두 가지 주요 부문으로 구성되어 있으며, 심부전 치료에 폭넓게 적용됨에 따라 VAD가 시장 점유율의 약 60%를 차지하고 있습니다. 주요 제품 카테고리에는 이식형 기기와 비이식형 기기가 있으며, 이식형 기기의 보급률이 높습니다. 시장은 어느 정도 통합되어 있으며, 소수의 주요 기업들이 시장을 독점하고 있습니다. 수량 면에서 볼 때, 시장에는 연간 수천 대가 도입되고 있으며, 이는 첨단 심장 치료 솔루션에 대한 수요가 증가하고 있음을 반영합니다.

인공심장 시장은 유형별로 세분화되어 있으며, 전체 인공심장(TAH)과 심실 보조 장치(VAD)가 주요 하위 부문으로 자리 잡고 있습니다. TAH는 심장 전체를 대체하도록 설계되었으며, 주로 이식을 기다리는 말기 심부전 환자에게 사용됩니다. VAD, 특히 좌심실 보조 장치(LVAD)는 이식 전까지의 가교 요법이나 최종 치료법으로 널리 사용되고 있어 시장을 독점하고 있습니다. 심부전 유병률 증가와 의료기기 기술의 발전이 이 부문 수요를 견인하고 있습니다.

이 제품은 이식 전의 가교 요법, 영구 치료 및 기타 용도에 중점을 두고 있습니다. 인공심장은 기증자 장기를 기다리는 환자에게 필수적이기 때문에 이식 전까지의 가교 요법이 여전히 주요 용도로 사용되고 있습니다. 그러나 특히 이식 대상이 아닌 환자들 사이에서 영구적인 치료법이 주목받고 있습니다. 이러한 추세는 고령화와 만성 심장 질환 증가에 힘입어 가속화되고 있으며, 장기적인 해결책의 필요성을 여실히 보여주고 있습니다.

지역별 개요

북미는 첨단 의료 인프라, 유리한 보험 급여 제도, 그리고 심혈관 기술의 광범위한 도입으로 인해 인공심장 시장을 주도할 것으로 예측됩니다. 이 지역은 심부전 및 심혈관 질환으로 인한 큰 부담에 직면해 있어, 인공심장 장치와 기계적 순환 보조 시스템에 대한 수요가 크게 증가하고 있습니다. 주요 의료기기 제조업체, 연구 기관 및 전문 심장 센터들이 지속적인 기술 발전과 임상 도입에 기여하고 있습니다. 또한, 막대한 의료비 지출과 혁신적인 심장 치료에 대한 투자 확대가 시장 성장을 뒷받침하고 있습니다. 숙련된 의료 인력의 확보와 첨단 의료기기에 대한 엄격한 규제 승인 절차가 북미 시장에서의 리더십을 더욱 공고히 하고 있습니다.

아시아태평양은 심혈관 질환 유병률 증가와 고품질 의료 서비스에 대한 접근성 개선으로 인해 인공심장 시장에서 가장 높은 연평균 성장률(CAGR)을 보일 것으로 예측됩니다. 중국, 인도, 일본, 한국 등에서는 심장 의료 인프라 확충이 진행되고 있으며, 전문 치료 시설에 대한 투자가 증가하고 있습니다. 의료비 증가, 보험 적용 범위 확대, 그리고 첨단 치료 옵션에 대한 인식 제고가 인공심장 기술의 도입을 촉진하고 있습니다. 또한, 이 지역은 환자 수가 많다는 점과 의료 혁신에 대한 정부의 지원 강화라는 혜택도 누리고 있습니다. 의료 시스템의 현대화와 접근성 개선에 따라 인공심장 솔루션에 대한 수요가 급격히 증가할 것으로 예측됩니다.

주요 동향 및 촉진요인

완전 내장형 인공심장 시스템의 개발:

인공심장 시장의 주요 동향 중 하나는 환자의 이동성, 편의성 및 장기적인 치료 성과를 향상시키는 것을 목표로 하는 완전 이식형 인공심장 시스템의 개발입니다. 제조업체와 연구 기관들은 장치의 소형화, 배터리 성능 향상, 그리고 감염 위험을 높이는 외부 구동 라인 부품의 제거에 주력하고 있습니다. 생체 재료, 전력 관리 시스템 및 소형화 기술의 발전이 혁신을 가속화하고 있습니다. 이러한 차세대 기기는 말기 심부전 환자에게 보다 영구적인 치료 옵션을 제공하는 것을 목표로 하고 있습니다. 임상시험이 진행되고 기술력이 향상됨에 따라, 완전 이식형 시스템은 심장 대체 요법의 미래를 일변시킬 것으로 예측됩니다.

말기 심부전 유병률 증가:

중증 심혈관 질환 및 말기 심부전의 유병률 증가는 인공심장 시장의 주요 성장 동력이 되고 있습니다. 고령화, 운동 부족, 비만, 당뇨병, 고혈압 등이 전 세계적으로 심해지면서 심장 질환 발병률 증가에 기여하고 있습니다. 동시에, 기증자 심장 부족으로 인해 기존의 심장 이식 수술 건수는 여전히 제한적입니다. 인공심장은 이식 대기 중인 환자나 기증자 장기를 받을 수 없는 환자에게 대체 치료 옵션을 제공합니다. 의료진이 진행성 심부전 관리를 위한 효과적인 해결책을 모색함에 따라, 전 세계 의료 시스템에서 인공심장 기술에 대한 수요는 꾸준히 증가할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 당사에 대해

JHS

The global artificial heart market is projected to grow from $3.5 billion in 2025 to $6.9 billion by 2035, at a compound annual growth rate (CAGR) of 6.7%. The artificial heart market is characterized by two leading segments: total artificial hearts (TAH) and ventricular assist devices (VAD), with VADs holding approximately 60% of the market share due to their broader application in heart failure management. Key product categories include implantable and external devices, with implantable devices being more prevalent. The market is moderately consolidated, with a few key players dominating the landscape. In terms of volume, the market sees thousands of units installed annually, reflecting the growing demand for advanced cardiac solutions.

The artificial heart market is segmented by type, with total artificial hearts (TAH) and ventricular assist devices (VAD) being the primary subsegments. TAHs are designed to replace the entire heart, primarily used in patients with end-stage heart failure awaiting transplantation. VADs, particularly left ventricular assist devices (LVADs), dominate the market due to their widespread use in bridging patients to transplant or as destination therapy. The increasing prevalence of heart failure and advancements in device technology drive demand in this segment.

Market Segmentation
TypeTotal Artificial Heart, Ventricular Assist Devices, Others
ProductImplantable Artificial Heart, Extracorporeal Artificial Heart, Others
TechnologyPneumatic, Electromechanical, Hydraulic, Others
ComponentBlood Pump, Controller, Power Source, Others
ApplicationBridge to Transplant, Destination Therapy, Bridge to Recovery, Others
Material TypeBiocompatible Polymers, Titanium Alloys, Ceramics, Others
DeviceWearable Artificial Heart, Implantable Artificial Heart, Others
End UserHospitals, Specialty Clinics, Research Institutes, Others
FunctionalitySingle Chamber, Dual Chamber, Others
SolutionsHeart Monitoring, Remote Monitoring, Others

The application segment focuses on bridge-to-transplant, destination therapy, and other applications. Bridge-to-transplant remains a dominant application, as artificial hearts are crucial for patients awaiting donor organs. However, destination therapy is gaining traction, especially among patients ineligible for transplantation. This trend is driven by the aging population and the increasing incidence of chronic heart conditions, highlighting the need for long-term solutions.

Geographical Overview

North America is anticipated to dominate the Artificial Heart Market owing to advanced healthcare infrastructure, favorable reimbursement systems, and extensive adoption of cardiovascular technologies. The region faces a significant burden of heart failure and cardiovascular diseases, creating strong demand for artificial heart devices and mechanical circulatory support systems. Leading medical device manufacturers, research institutions, and specialized cardiac centers contribute to continuous technological advancement and clinical adoption. Furthermore, substantial healthcare spending and increasing investments in innovative cardiac therapies support market expansion. The availability of skilled healthcare professionals and strong regulatory pathways for advanced medical devices further reinforce North America's market leadership.

Asia Pacific is expected to record the highest CAGR in the Artificial Heart Market due to rising cardiovascular disease prevalence and improving access to advanced healthcare services. Countries such as China, India, Japan, and South Korea are expanding cardiac care infrastructure and increasing investments in specialized treatment facilities. Growing healthcare expenditure, improving insurance coverage, and rising awareness regarding advanced treatment options are encouraging adoption of artificial heart technologies. The region also benefits from a large patient population and increasing government support for medical innovation. As healthcare systems modernize and access improves, demand for artificial heart solutions is expected to rise rapidly.

Key Trends and Drivers

Development of Fully Implantable Artificial Heart Systems:

A major trend in the Artificial Heart Market is the development of fully implantable artificial heart systems designed to improve patient mobility, comfort, and long-term outcomes. Manufacturers and research institutions are focusing on reducing device size, enhancing battery performance, and eliminating external driveline components that increase infection risks. Advances in biomaterials, power management systems, and miniaturized engineering technologies are accelerating innovation. These next-generation devices aim to provide a more permanent treatment option for patients with end-stage heart failure. As clinical trials progress and technological capabilities improve, fully implantable systems are expected to transform the future of cardiac replacement therapies.

Increasing Prevalence of End-Stage Heart Failure:

The growing prevalence of severe cardiovascular diseases and end-stage heart failure is a primary driver of the Artificial Heart Market. Aging populations, sedentary lifestyles, obesity, diabetes, and hypertension are contributing to rising rates of advanced cardiac conditions worldwide. At the same time, the shortage of donor hearts continues to limit the availability of traditional heart transplantation procedures. Artificial hearts provide an alternative treatment option for patients awaiting transplantation or those ineligible for donor organs. As healthcare providers seek effective solutions for managing advanced heart failure, demand for artificial heart technologies is expected to increase steadily across global healthcare systems.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Total Artificial Heart
    • 4.1.2 Ventricular Assist Devices
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Implantable Artificial Heart
    • 4.2.2 Extracorporeal Artificial Heart
    • 4.2.3 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Pneumatic
    • 4.3.2 Electromechanical
    • 4.3.3 Hydraulic
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Blood Pump
    • 4.4.2 Controller
    • 4.4.3 Power Source
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Bridge to Transplant
    • 4.5.2 Destination Therapy
    • 4.5.3 Bridge to Recovery
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Biocompatible Polymers
    • 4.6.2 Titanium Alloys
    • 4.6.3 Ceramics
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Wearable Artificial Heart
    • 4.7.2 Implantable Artificial Heart
    • 4.7.3 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Specialty Clinics
    • 4.8.3 Research Institutes
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Single Chamber
    • 4.9.2 Dual Chamber
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Heart Monitoring
    • 4.10.2 Remote Monitoring
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 Device
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 Device
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 Device
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 Device
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 Device
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 Device
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 Device
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 Device
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 Device
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 Device
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 Device
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 Device
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 Device
      • 5.4.7.8 End User
      • 5.4.7.9 Functionality
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 Device
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 Device
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 Device
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 Device
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 Device
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 Device
      • 5.5.6.8 End User
      • 5.5.6.9 Functionality
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 Device
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 Device
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 Device
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 Device
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 Device
      • 5.6.5.8 End User
      • 5.6.5.9 Functionality
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 SynCardia Systems
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Carmat
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Abiomed
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 BiVACOR
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Thoratec Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 HeartWare International
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Berlin Heart
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 ReliantHeart
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Jarvik Heart
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 CorWave
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Evaheart
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 CardioWest
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bivacor
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Cleveland Heart
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Calon Cardio-Technology
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Cirtec Medical
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 WorldHeart
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 MyLVAD
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 MicroMed Cardiovascular
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Ventracor
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기